SPDL1 and alkaline phosphatase measurement: Serum sPD‐1/sPD‐L1 levels may be involved in the immunosuppressive process of AP, and sPD‐1, which increases continuously in the peripheral blood of AP patients, maybe an independent risk factor for predicting ICs in AP patients, which is potentially applicable in determining or improving AP patient prognosis.